1. Home
  2. HHS vs XGN Comparison

HHS vs XGN Comparison

Compare HHS & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harte-Hanks Inc.

HHS

Harte-Hanks Inc.

HOLD

Current Price

$4.62

Market Cap

17.7M

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$8.74

Market Cap

110.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HHS
XGN
Founded
1923
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
110.7M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
HHS
XGN
Price
$4.62
$8.74
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
119.6K
226.3K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
97.35
N/A
EPS
N/A
N/A
Revenue
$159,570,000.00
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$2.59
52 Week High
$4.67
$12.23

Technical Indicators

Market Signals
Indicator
HHS
XGN
Relative Strength Index (RSI) 73.22 74.71
Support Level $4.14 $4.08
Resistance Level N/A N/A
Average True Range (ATR) 0.12 0.39
MACD -0.02 0.08
Stochastic Oscillator 90.57 95.98

Price Performance

Historical Comparison
HHS
XGN

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: